Enhanced Recovery Pathway Reduced Opioid Use and Pain Scores in Elective Spine Surgery.

Journal of surgical orthopaedic advances Pub Date : 2024-01-01

Logan A Reed, Kevin Luque-Sanchez, Alexander Mihas, Eli B Levitt, Roland T Short, Christopher A Godlewski, Steven M Theiss

{"title":"Enhanced Recovery Pathway Reduced Opioid Use and Pain Scores in Elective Spine Surgery.","authors":"Logan A Reed, Kevin Luque-Sanchez, Alexander Mihas, Eli B Levitt, Roland T Short, Christopher A Godlewski, Steven M Theiss","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The purpose of this study was to determine if implementation of an enhanced recovery pathway (ERP) for elective spine surgery reduced opioid use and pain scores in elective spine surgery. A historical cohort study of 171 patients undergoing elective spine procedures between 2017 and 2021 was performed. The primary outcomes were opioid use and average daily pain scores. A group of 92 patients received the novel ERP (2019 - 2021) in comparison to a historical control group of 79 patients without the ERP (2017 - 2019). On postoperative days 1 to 3, the ERP group received 36% (p < 0.001), 36% (p < 0.001), and 37% (p = 0.005) less milligram morphine equivalents, respectively. On postoperative days 1 to 3, the ERP group pain scores were 1.5 (p < 0.001), 1.0 (p = 0.003), and 1.1 (p = 0.004) points lower, respectively. Length of stay was similar (4.3 vs. 4.5 days, p = 0.693). Adoption of this ERP protocol was associated with clinically significant reduced opioid consumption and pain scores in elective spine surgery. (Journal of Surgical Orthopaedic Advances 33(3):162-167, 2024).</p>","PeriodicalId":516534,"journal":{"name":"Journal of surgical orthopaedic advances","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of surgical orthopaedic advances","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

The purpose of this study was to determine if implementation of an enhanced recovery pathway (ERP) for elective spine surgery reduced opioid use and pain scores in elective spine surgery. A historical cohort study of 171 patients undergoing elective spine procedures between 2017 and 2021 was performed. The primary outcomes were opioid use and average daily pain scores. A group of 92 patients received the novel ERP (2019 - 2021) in comparison to a historical control group of 79 patients without the ERP (2017 - 2019). On postoperative days 1 to 3, the ERP group received 36% (p < 0.001), 36% (p < 0.001), and 37% (p = 0.005) less milligram morphine equivalents, respectively. On postoperative days 1 to 3, the ERP group pain scores were 1.5 (p < 0.001), 1.0 (p = 0.003), and 1.1 (p = 0.004) points lower, respectively. Length of stay was similar (4.3 vs. 4.5 days, p = 0.693). Adoption of this ERP protocol was associated with clinically significant reduced opioid consumption and pain scores in elective spine surgery. (Journal of Surgical Orthopaedic Advances 33(3):162-167, 2024).

本刊更多论文

强化康复路径减少了脊柱外科手术中阿片类药物的使用和疼痛评分。

本研究旨在确定在脊柱择期手术中实施增强型恢复路径（ERP）是否会减少脊柱择期手术中阿片类药物的使用和疼痛评分。该研究对 2017 年至 2021 年间接受择期脊柱手术的 171 名患者进行了历史队列研究。研究的主要结果是阿片类药物的使用量和每日平均疼痛评分。92名患者接受了新型ERP（2019-2021年），而79名患者未接受ERP（2017-2019年）。在术后第1至3天，ERP组的吗啡毫克当量分别减少了36%（p < 0.001）、36%（p < 0.001）和37%（p = 0.005）。术后第1至3天，ERP组的疼痛评分分别降低了1.5分（p < 0.001）、1.0分（p = 0.003）和1.1分（p = 0.004）。住院时间相似（4.3 对 4.5 天，p = 0.693）。在择期脊柱手术中，采用该 ERP 方案可显著减少阿片类药物的用量和疼痛评分。(外科骨科进展杂志》33（3）：162-167，2024 年）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of surgical orthopaedic advances

自引率

0.00%

发文量